BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Kelley CE, Brown AJ, Diehl AM, Setji TL. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol 2014; 20(39): 14172-14184 [PMID: 25339805 DOI: 10.3748/wjg.v20.i39.14172]
URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14172.htm
(431) (337) (0) (0) (11680) (81)
Number Citing Articles
1
Xinyu Hong, Zaixin Guo, Qi Yu. Hepatic steatosis in women with polycystic ovary syndrome. BMC Endocrine Disorders 2023; 23(1) doi: 10.1186/s12902-023-01456-6
2
W.-Y. Cai, J.-S. Gao, X. Luo, H.-L. Ma, H. Ge, N. Liu, Q. Xia, Y. Wang, B.-W. Han, X.-K. Wu. Effects of metabolic abnormalities, hyperandrogenemia and clomiphene on liver function parameters among Chinese women with polycystic ovary syndrome: results from a randomized controlled trial. Journal of Endocrinological Investigation 2019; 42(5) doi: 10.1007/s40618-018-0953-6
3
Nicolás Salva-Pastor, Guillermo Nahúm López-Sánchez, Norberto Carlos Chávez-Tapia, Jorge Román Audifred-Salomón, Danniela Niebla-Cárdenas, Rafael Topete-Estrada, Helga Pereznuñez-Zamora, Rafael Vidaltamayo-Ramírez, Margarita Elodia Báez-Arellano, Misael Uribe, Natalia Nuño-Lámbarri. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population. Annals of Hepatology 2020; 19(3) doi: 10.1016/j.aohep.2020.01.004
4
Amna Naveed, Rachana Shah, Angelina Bernier, Valeriia Muradova, Eray Savgan Gurol, Melanie Cree, Rachel Whooten. Metabolic Implications of PCOS. Current Pediatrics Reports 2025; 13(1) doi: 10.1007/s40124-025-00364-8
5
A. L. L. Rocha, L. C. Faria, T. C. M. Guimarães, G. V. Moreira, A. L. Cândido, C. A. Couto, F. M. Reis. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. Journal of Endocrinological Investigation 2017; 40(12) doi: 10.1007/s40618-017-0708-9
6
Jianhai Zhang, Jian Hu, Chunxia Zhang, Yanni Jiao, Xiang Kong, Wei Wang. Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5932
7
Raksha Rani, Younis Ahmad Hajam, Rajesh Kumar, Rouf Ahmad Bhat, Seema Rai, Manzoor Ahmad Rather. A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS). Phytomedicine Plus 2022; 2(1) doi: 10.1016/j.phyplu.2021.100161
8
. 2022;  doi: 10.70675/073be3a9z5b22z4f29z8119zbc33755b0eb9
9
Parisa Sadat Pournaderi, Parichehreh Yaghmaei, Hamidreza Khodaei, Zahra Noormohammadi, Seyed Hossein Hejazi. The effects of 6-Gingerol on reproductive improvement, liver functioning and Cyclooxygenase-2 gene expression in estradiol valerate – Induced polycystic ovary syndrome in Wistar rats. Biochemical and Biophysical Research Communications 2017; 484(2) doi: 10.1016/j.bbrc.2017.01.057
10
Lihong Liu, Bo Du, Haiying Zhang, Xiaofei Guo, Zheng Zhou, Aihui Xiu, Chang Liu, Shiyu Su, Hao Ai. A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome. Chinese Medicine 2018; 13(1) doi: 10.1186/s13020-018-0201-1
11
Cristina Maria Marginean, Denisa Pirscoveanu, Sergiu Marian Cazacu, Marian Sorin Popescu, Iulia Cristina Marginean, George Alexandru Iacob, Mihaela Popescu. Non-Alcoholic Fatty Liver Disease, Awareness of a Diagnostic Challenge—A Clinician’s Perspective. Gastroenterology Insights 2024; 15(4) doi: 10.3390/gastroent15040071
12
Z. Esmaeilinezhad, S. Babajafari, Z. Sohrabi, M.-H. Eskandari, S. Amooee, R. Barati-Boldaji. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutrition, Metabolism and Cardiovascular Diseases 2019; 29(2) doi: 10.1016/j.numecd.2018.07.002
13
Linjie Chen, Zhifen Zhang, Jian Huang, Minjuan Jin. Association between rs1800795 polymorphism in the interleukin-6 gene and the risk of polycystic ovary syndrome. Medicine 2018; 97(29) doi: 10.1097/MD.0000000000011558
14
Avni Mody, Donna White, Fasiha Kanwal, Jose M. Garcia. Relevance of low testosterone to nonalcoholic fatty liver disease. Cardiovascular Endocrinology 2015; 4(3) doi: 10.1097/XCE.0000000000000057
15
Filomena Morisco, Raffaele Bruno, Elisabetta Bugianesi, Patrizia Burra, Vincenza Calvaruso, Alice Cannoni, Nicola Caporaso, Gian Paolo Caviglia, Alessia Ciancio, Silvia Fargion, Alessandro Federico, Annarosa Floreani, Giovanni Battista Gaeta, Maria Guarino, Pietro Invernizzi, Anna Licata, Carmela Loguercio, Giuseppe Mazzella, Felice Petraglia, Massimo Primignani, Kryssia Rodriguez-Castro, Antonina Smedile, Luca Valenti, Ester Vanni, Silvia Vannuccini, Chiara Voltolini, Erica Villa. AISF position paper on liver disease and pregnancy. Digestive and Liver Disease 2016; 48(2) doi: 10.1016/j.dld.2015.11.004
16
Snehanjali Puhan, Smaroki Smruti Rekha, Kartika Sahu, Tanuja Mohanty, Arka Jyoti De, Ankita Das, Palok Aich. Visiting MASLD through the lens of sex, immunity, and microbial interactions. Discover Medicine 2025; 2(1) doi: 10.1007/s44337-025-00489-1
17
Mariana Lazo, Irfan Zeb, Khurram Nasir, Russell P. Tracy, Matthew J. Budoff, Pamela Ouyang, Dhananjay Vaidya. Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. Clinical Gastroenterology and Hepatology 2015; 13(9) doi: 10.1016/j.cgh.2014.12.033
18
Raseen Tariq, Page Axley, Ashwani K. Singal. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review. Journal of Clinical and Experimental Hepatology 2020; 10(1) doi: 10.1016/j.jceh.2019.07.008
19
Suvarthi Das, Firas Alhasson, Diptadip Dattaroy, Sahar Pourhoseini, Ratanesh Kumar Seth, Mitzi Nagarkatti, Prakash S. Nagarkatti, Gregory A. Michelotti, Anna Mae Diehl, Balaraman Kalyanaraman, Saurabh Chatterjee. NADPH Oxidase–Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment. The American Journal of Pathology 2015; 185(7) doi: 10.1016/j.ajpath.2015.03.024
20
Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World Journal of Hepatology 2023; 15(6): 786-796 doi: 10.4254/wjh.v15.i6.786
21
Sindhuja Reddy Chada, Rakesh Kumar Sahay. Current and Emerging Concepts of Polycystic Ovary Syndrome – Manual from M.P. PCOS Society (Part 1). 2025;  doi: 10.2174/9798898810931125010014
22
Saurabh Chatterjee, Suvarthi Das. P2X7 Receptor as a Key Player in Oxidative Stress-Driven Cell Fate in Nonalcoholic Steatohepatitis. Oxidative Medicine and Cellular Longevity 2015; 2015 doi: 10.1155/2015/172493
23
Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Siwanart Kongarin, Karan Srisurapanont, Phakkamon Pingwang, Nonlawan Songmueang, Chalida Nonthasoot, Worapaka Manosroi, Surakit Nathisuwan, Fang Li, Ju Dong Yang, Vincent L. Chen, Donghee Kim, Mazen Noureddin, Daniel Q. Huang, Karn Wijarnpreecha. Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women. Mayo Clinic Proceedings 2024; 99(10) doi: 10.1016/j.mayocp.2023.12.025
24
Cunlin Zhang, Zhijia Yan, Xinmeng Xing, Yanan Tang, Liru Jia, Xingrong He, Junbai Ma, Xiaoyan Bai, Hao Wang, Yuan Lin, Xiaoxia Zhang. Sheep placental extract ameliorates polycystic ovary syndrome in rats by regulating ERβ-mediated Treg cells via the TGF-β1/Smad3 signaling pathway. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1777841
25
Lin Yin, Wanqiu Yang, Qingling Xie, Jili Xu, Ying Lan, Jie Wu. The role of traditional Chinese medicine in modulating gut microbiota to alleviating insulin resistance in polycystic ovary syndrome. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1700612
26
Ashley Graef, Monique J. LeMieux. The Interplay Between PMOS and MASLD: Pathophysiology and Evidence-Based Nutritional Interventions. Nutrients 2026; 18(12) doi: 10.3390/nu18121948
27
Samia Palat Tharayil, Pallavi Shukla. Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance—Insights and Therapeutic Advances. International Journal of Molecular Sciences 2025; 26(13) doi: 10.3390/ijms26136233
28
Eda Kaya, Yusuf Yilmaz. Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. Journal of Clinical and Translational Hepatology 2022; 10(2) doi: 10.14218/JCTH.2021.00178
29
Monika Sarkar, Melissa Wellons, Marcelle I Cedars, Lisa VanWagner, Erica P Gunderson, Veeral Ajmera, Laura Torchen, David Siscovick, Jeffrey J Carr, James G Terry, Mary Rinella, Cora E Lewis, Norah Terrault. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. American Journal of Gastroenterology 2017; 112(5) doi: 10.1038/ajg.2017.44
30
Sikandar Hayat Khan, Farah Sobia, Najmusaqib Khan Niazi, Syed Mohsin Manzoor, Nadeem Fazal, Fowad Ahmad. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetology & Metabolic Syndrome 2018; 10(1) doi: 10.1186/s13098-018-0376-8
31
Alirez Sadeghi, Kurosh Djafarian, Hamed Mohammadi, Sakineh Shab-Bidar. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017; 11(2) doi: 10.1016/j.dsx.2016.06.025
32
Jéssica A. G. Tosatti, Michelle T. Alves, Ana L. Cândido, Fernando M. Reis, Vânia E. Araújo, Karina B. Gomes. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. British Journal of Nutrition 2021; 125(6) doi: 10.1017/S0007114520003207
33
Claire Falzarano, Taylor Lofton, Adjoa Osei-Ntansah, Trinitee Oliver, Taylor Southward, Salim Stewart, Stanley Andrisse. Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 2022; 107(1) doi: 10.1210/clinem/dgab658
34
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
35
Abdulrahman Ismaiel, Piero Portincasa, Dan L. Dumitrascu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023;  doi: 10.1007/978-3-031-33548-8_3
36
Xusong Hu, Xuechun Weng, Ye Tian, Chengtao Wang, Yanzhou Yang, Kaili Xu, Cheng Zhang. Effects of omega-3 polyunsaturated fatty acids on steroidogenesis and cellular development in PCOS rats. Food & Function 2019; 10(5) doi: 10.1039/C8FO02319K
37
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>&reg;</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?. World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
38
Ratan Dasgupta. Growth Curve Models and Applications. Springer Proceedings in Mathematics & Statistics 2017; 204 doi: 10.1007/978-3-319-63886-7_3
39
Dejana Rakic, Vladimir Jakovljevic, Nikola Jovic, Marija Bicanin Ilic, Aleksandra Dimitrijevic, Tatjana Vulovic, Petar Arsenijevic, Jasmina Sretenovic, Maja Nikolic, Vladimir Petrovich Fisenko, Stefani Bolevich, Gala Zarkovic, Jovana Joksimovic Jovic. The Potential of SGLT-2 Inhibitors in the Treatment of Polycystic Ovary Syndrome: The Current Status and Future Perspectives. Biomedicines 2023; 11(4) doi: 10.3390/biomedicines11040998
40
Marieke Tebbens, Moya Schutte, Marian A Troelstra, Eveline Bruinstroop, Renée de Mutsert, Aart J Nederveen, Martin den Heijer, Peter H Bisschop. Sex Steroids Regulate Liver Fat Content and Body Fat Distribution in Both Men and Women: A Study in Transgender Persons. The Journal of Clinical Endocrinology & Metabolism 2023; 109(1) doi: 10.1210/clinem/dgad409
41
Rashmi Kudesia, Hina J. Talib, Staci E. Pollack. Fertility Awareness Counseling for Adolescent Girls; Guiding Conception: The Right Time, Right Weight, and Right Way. Journal of Pediatric and Adolescent Gynecology 2017; 30(1) doi: 10.1016/j.jpag.2016.07.004
42
Michael Freemark. Pediatric Obesity. Contemporary Endocrinology 2018;  doi: 10.1007/978-3-319-68192-4_19
43
M. A. Livzan, O. V. Gaus, N. A. Nikolaev, T. S. Krolevetz. NAFLD: comorbidity and associated diseases. Experimental and Clinical Gastroenterology 2020; 1(10) doi: 10.31146/1682-8658-ecg-170-10-57-65
44
Minqian Shen, Haifei Shi. Sex Hormones and Their Receptors Regulate Liver Energy Homeostasis. International Journal of Endocrinology 2015; 2015 doi: 10.1155/2015/294278
45
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
46
Omer Tammo. Understanding Polycystic Ovary Syndrome - Symptoms, Diagnosis, and Treatment Options. Obstetrics and Gynecology 2025; 11 doi: 10.5772/intechopen.1010597
47
Zeliha Yetim, Kübra Şevgin, Seda Yakut. HEPATOPROTECTIVE ROLE OF NICOTINAMIDE MONONUCLEOTIDE IN PCOS: HISTOPATHOLOGICAL AND BIOCHEMICAL EVIDENCE FROM A RAT MODEL. Acta Medica Nicomedia 2026; 9 doi: 10.53446/actamednicomedia.1844671
48
Hongxia Deng, Yan Chen, Jilong Xing, Nannan Zhang, Liangzhi Xu. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1470283
49
Unaiza Qamar, Stephen L. Atkin, Thozhukat Sathyapalan. Practical Guide to Obesity Medicine. 2018;  doi: 10.1016/B978-0-323-48559-3.00006-3
50
Hafeja Akhter Hima, Md Abdul Hannan Miah, Nipa Rani Ghosh, Sazia Sultana, Tanjina Akter, Fatema Tuz Zahura Aalpona, A. B. M. Kamrul-Hasan. Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome. Bangladesh Journal of Endocrinology and Metabolism 2023; 2(2) doi: 10.4103/bjem.bjem_10_23
51
Dalia M. Miller, Kiana F. McCauley, Kimberly J. Dunham‐Snary. Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances. Endocrinology, Diabetes & Metabolism 2025; 8(6) doi: 10.1002/edm2.70132
52
Kailin Yang, Liuting Zeng, Tingting Bao, Jinwen Ge. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology and Endocrinology 2018; 16(1) doi: 10.1186/s12958-018-0346-x
53
Andrew A. Li, Aijaz Ahmed, Donghee Kim. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Gut and Liver 2020; 14(2) doi: 10.5009/gnl19069
54
Ratan Dasgupta, Anwesha Pan. Growth Curve and Structural Equation Modeling. Springer Proceedings in Mathematics & Statistics 2015; 132 doi: 10.1007/978-3-319-17329-0_8
55
Sambit Roy, Aierken Abudu, Irving Salinas, Niharika Sinha, Holly Cline-Fedewa, Alexandra M Yaw, Wenjie Qi, Todd A Lydic, Diana L Takahashi, Jon D Hennebold, Hanne M Hoffmann, Jianrong Wang, Aritro Sen. Androgen-mediated Perturbation of the Hepatic Circadian System Through Epigenetic Modulation Promotes NAFLD in PCOS Mice. Endocrinology 2022; 163(10) doi: 10.1210/endocr/bqac127
56
Tsung-Sheng Chen, Yi-Ting Chen, Chia-Hsin Liu, Chi-Ching Sun, Frank Chiahung Mao. Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS. Gynecological Endocrinology 2017; 33(1) doi: 10.1080/09513590.2016.1205579
57
Aikaterini Giannouli, Vasiliki Efthymiou, Marianna Konidari, Iliana Mani, Leon Aravantinos, Spyridon P. Dourakis, Aristeidis Antoniou, Efthymios Deligeoroglou, Flora Bacopoulou. The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study. Journal of Clinical Medicine 2023; 12(2) doi: 10.3390/jcm12020557
58
HAOYU KUANG, XIAOLI HUA, JIANHUI ZHOU, RUI YANG. Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity. Oncology Reports 2016; 35(1) doi: 10.3892/or.2015.4389
59
Anoushka Shenoy, Aijaz Ahmed, Donghee Kim. Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease. Metabolism and Target Organ Damage 2025; 5(3) doi: 10.20517/mtod.2025.73
60
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand. Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. Journal of Clinical and Translational Hepatology 2019; (X) doi: 10.14218/JCTH.2019.00051
61
Xiaoshu Ma, Xuechun Weng, Xusong Hu, Qiaozhi Wang, Ye Tian, Yu Ding, Cheng Zhang. Roles of different n-3/n-6 PUFA ratios in ovarian cell development and steroidogenesis in PCOS rats. Food & Function 2019; 10(11) doi: 10.1039/C9FO01730E
62
Devaraj Ezhilarasan. Critical role of estrogen in the progression of chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2020; 19(5) doi: 10.1016/j.hbpd.2020.03.011
63
Luca Valenti, Stefano Romeo. Destined to develop NAFLD? The predictors of fatty liver from birth to adulthood. Journal of Hepatology 2016; 65(4) doi: 10.1016/j.jhep.2016.06.010
64
WEI CHEN, XIAOWEI WANG, LI HUANG, BO LIU. Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine 2016; 11(1) doi: 10.3892/etm.2015.2873
65
Giovanni Targher, Maurizio Rossini, Amedeo Lonardo. Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?. Endocrine 2016; 51(2) doi: 10.1007/s12020-015-0640-8
66
Zhao-Chun Chi. Research status and progress of metabolic associated fatty liver disease. World Chinese Journal of Digestology 2022; 30(1) doi: 10.11569/wcjd.v30.i1.1
Abstract(0) |  Core Tip(0) |  Full Article(HTML)(0) | Times Cited (1) | Total Visits (0) | Open
67
Ancong Wang, Min Liu, Weilong Li, Dongyi Zhu, Qihua Tan. Epigenetic heterogeneity in women with polycystic ovary syndrome. Molecular and Cellular Endocrinology 2026; 618 doi: 10.1016/j.mce.2026.112807
68
Rui Zhu, Xinzhe Wang, Jingyun Ma, Xiuwen Shi, Yizhu Zhang, Jing Jin, Huifang Zhou. Hepatokines and polycystic ovary syndrome: investigating the connection between the hepato-ovarian axis and disorders in glycolipid metabolism in PCOS: a narrative review. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1598164
69
Yong Chen, Leikai Ma, Zhouling Ge, Yizhao Pan, Lubin Xie. Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.888194
70
Nasser Alorfi, Ahmed Ashour. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry. Diabetes, Metabolic Syndrome and Obesity 2023;  doi: 10.2147/DMSO.S430740
71
Masataka Seike. The Liver in Systemic Diseases. 2016;  doi: 10.1007/978-4-431-55790-6_12
72
Chunwei Walter Lai, Sneha Jadhav, Basile Njei, Aijun Ye, Jean Wactawski-Wende, Sunni L. Mumford, Enrique F. Schisterman, Yaron Rotman. Rhythmic Fluctuations in Levels of Liver Enzymes During Menstrual Cycles of Healthy Women and Effects of Body Weight. Clinical Gastroenterology and Hepatology 2020; 18(9) doi: 10.1016/j.cgh.2019.11.047
73
Juan Wang, Daichao Wu, Hui Guo, Meixiang Li. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sciences 2019; 236 doi: 10.1016/j.lfs.2019.116940
74
Ilay Gozukara, Recep Dokuyucu, Tümay Özgür, Oguzhan Özcan, Neslihan Pınar, Raziye Keskin Kurt, Suna Kabil Kucur, Kenan Dolapcioglu. Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model. Gynecological Endocrinology 2016; 32(6) doi: 10.3109/09513590.2015.1134478
75
Lisa B. VanWagner, Mary E. Rinella. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2) doi: 10.1007/s11901-016-0295-9
76
Bitasta Mandal, Rakesh Das, Sandip Mondal. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises 2024; 82(3) doi: 10.1016/j.pharma.2024.02.005
77
Mehmet Sayiner, Munkhzul Otgonsuren, Rebecca Cable, Issah Younossi, Mariam Afendy, Pegah Golabi, Linda Henry, Zobair M. Younossi. Variables Associated With Inpatient and Outpatient Resource Utilization Among Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease With or Without Cirrhosis. Journal of Clinical Gastroenterology 2017; 51(3) doi: 10.1097/MCG.0000000000000567
78
Nafiye Helvaci, Bulent Okan Yildiz. Polycystic ovary syndrome as a metabolic disease. Nature Reviews Endocrinology 2025; 21(4) doi: 10.1038/s41574-024-01057-w
79
Chao-Wu Xiao, Adriana A. Carbonel, Patricia D. A. Lima, Amy Hendry, Benjamin K. Tsang. Consumption of soya isoflavones improved polycystic ovary syndrome-associated metabolic disorders in a rat model. British Journal of Nutrition 2024; 132(4) doi: 10.1017/S0007114524001296
80
Zhao Wu, Guining Liang, Ying Zhang, Renyuan Li. Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Polycystic Ovary Syndrome in East Asia: A Review and Meta-Analysis. Endocrine Practice 2025; 31(5) doi: 10.1016/j.eprac.2025.01.011
81
Hye-In Kim, Joo-Hyun Park, Do-Hoon Kim, Hyun-Jin Kim, An-Na Lee, Jung-Hwa Shin, Chae-Won Baek, Min-Hae Lee. Association between liver function markers and menstrual cycle irregularity in Korean female population. Korean Journal of Family Medicine 2025; 46(5) doi: 10.4082/kjfm.23.0181
82
Kara Wegermann, Ayako Suzuki, Alisha M. Mavis, Manal F. Abdelmalek, Anna Mae Diehl, Cynthia A. Moylan. REPLY:. Hepatology 2021; 73(4) doi: 10.1002/hep.31593
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.